CMPS

MKT CAP:$905M

COMPASS Pathways plc

Market Cap

$905M

Healthcare·Medical - Care Facilities·🇬🇧 United Kingdom·NASDAQ

Healthcare·Medical·🇬🇧·NASDAQ

Stock Price

$8.75+$2.20 (+33.59%)

Apr 22, 2026

Company Details

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resis...

CEO

Kabir Kumar Nath

IPO Date

Sep 18, 2020

Website

compasspathways.com

Key Metrics TTM

Revenue

$0

— YoY

Net Income

-$288M

EPS (Diluted)

-$3.09

Free Cash Flow

-$157M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

Q1 2026

May 14, 2026

PENDING

FY 2025

Mar 24, 2026

$0EPS -$3.08

Q4 2025

Mar 24, 2026

$0EPS -$1.00

Q3 2025

Nov 4, 2025

$0EPS -$1.44

Q2 2025

Jul 31, 2025

$0EPS -$0.41

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$0	$0	-$25M
Q2 22	$0	$0	-$27M
Q3 22	$0	$0	-$26M
Q4 22	$0	$0	-$32M
Q1 23	$0	$0	-$32M
Q2 23	$0	$0	-$33M
Q3 23	$0	$0	-$34M
Q4 23	$0	$0	-$38M
Q1 24	$0	$0	-$39M
Q2 24	$0	$0	-$43M
Q3 24	$0	$0	-$48M
Q4 24	$0	$0	-$48M
Q1 25	$0	$0	-$50M
Q2 25	$0	$0	-$43M
Q3 25	$0	$0	-$41M
Q4 25	$0	-$6.0K	-$46M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$23M	-$23M
Q2 22	-$18M	-$18M
Q3 22	-$19M	-$19M
Q4 22	-$45M	-$45M
Q1 23	-$28M	-$28M
Q2 23	-$25M	-$25M
Q3 23	-$17M	-$17M
Q4 23	-$28M	-$28M
Q1 24	-$21M	-$21M
Q2 24	-$34M	-$34M
Q3 24	-$22M	-$22M
Q4 24	-$42M	-$42M
Q1 25	-$46M	-$46M
Q2 25	-$39M	-$39M
Q3 25	-$35M	-$35M
Q4 25	-$38M	-$38M

Capital Expenditures

Quarter	CapEx
Q1 22	$82.0K
Q2 22	$412.0K
Q3 22	$5.0K
Q4 22	$107.0K
Q1 23	$29.0K
Q2 23	$19.0K
Q3 23	$18.0K
Q4 23	$0
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0
Q4 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	—	+86.9%
Q2 22	—	+39.6%
Q3 22	—	+17.3%
Q4 22	—	+13.7%
Q1 23	—	+25.1%
Q2 23	—	+19.8%
Q3 23	—	+33.4%
Q4 23	—	+19.3%
Q1 24	—	+21.3%
Q2 24	—	+32.6%
Q3 24	—	+40.6%
Q4 24	—	+26.1%
Q1 25	—	+28.6%
Q2 25	—	-0.9%
Q3 25	—	-15.4%
Q4 25	—	-5.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$3M	—
Q2 22	$3M	—
Q3 22	$4M	—
Q4 22	$3M	—
Q1 23	$4M	—
Q2 23	$5M	—
Q3 23	$4M	—
Q4 23	$4M	—
Q1 24	$5M	—
Q2 24	$5M	—
Q3 24	$5M	—
Q4 24	$4M	—
Q1 25	$4M	—
Q2 25	$4M	—
Q3 25	$0	—
Q4 25	$3M	—

OpEx Breakdown

Quarter	R&D	G&A
Q1 22	$15M	$10M
Q2 22	$16M	$11M
Q3 22	$14M	$12M
Q4 22	$20M	$12M
Q1 23	$19M	$13M
Q2 23	$20M	$13M
Q3 23	$22M	$13M
Q4 23	$27M	$11M
Q1 24	$25M	$14M
Q2 24	$29M	$14M
Q3 24	$33M	$15M
Q4 24	$32M	$16M
Q1 25	$31M	$19M
Q2 25	$30M	$13M
Q3 25	$23M	$13M
Q4 25	$30M	$16M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$244M	$0	$244M
Q2 22	$207M	$0	$207M
Q3 22	$173M	$0	$173M
Q4 22	$143M	$0	$143M
Q1 23	$117M	$0	$117M
Q2 23	$148M	$0	$148M
Q3 23	$248M	$0	$248M
Q4 23	$220M	$0	$220M
Q1 24	$263M	$0	$263M
Q2 24	$229M	$0	$229M
Q3 24	$207M	$0	$207M
Q4 24	$165M	$0	$165M
Q1 25	$260M	$0	$260M
Q2 25	$222M	$0	$222M
Q3 25	$186M	$0	$186M
Q4 25	$150M	$0	$150M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	42M	+0.5%	+15.0%
Q2 22	42M	+1.0%	+6.7%
Q3 22	43M	+0.1%	+2.0%
Q4 22	42M	-0.2%	+1.4%
Q1 23	43M	+0.7%	+1.6%
Q2 23	46M	+6.6%	+7.3%
Q3 23	50M	+8.9%	+16.7%
Q4 23	62M	+24.8%	+46.0%
Q1 24	64M	+3.6%	+50.3%
Q2 24	68M	+6.5%	+50.0%
Q3 24	68M	+0.0%	+37.8%
Q4 24	68M	+0.1%	+10.5%
Q1 25	89M	+30.3%	+38.9%
Q2 25	93M	+4.7%	+36.5%
Q3 25	95M	+2.1%	+39.4%
Q4 25	94M	-1.8%	+36.8%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$0	116
Q2 22	$0	116
Q3 22	$0	116
Q4 22	$0	181
Q1 23	$0	181
Q2 23	$0	181
Q3 23	$0	181
Q4 23	$0	186
Q1 24	$0	186
Q2 24	$0	186
Q3 24	$0	186
Q4 24	$0	166
Q1 25	$0	166
Q2 25	$0	166
Q3 25	$0	166
Q4 25	$0	156

Revenue / Employee